Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome

Human Reproduction

Volumn 22, Issue 2, 2007, Pages 389-394

  Amer, Saad A ^a,c   Laird, S ^b   Ledger, W L ^a   Li, T C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

Body mass index; Inhibin B; Laparoscopic ovarian diathermy; Ovulation; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; CLOMIFENE CITRATE; GONADOTROPIN; INHIBIN B;

ADULT; ANDROGEN BLOOD LEVEL; ANOVULATION; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIATHERMY; FEMALE; GONADOTROPIN BLOOD LEVEL; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; LAPAROSCOPIC SURGERY; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROSPECTIVE STUDY;

EID: 33846516537     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del373     Document Type: Article

References (39)

1. Adams J, Polson DW, Mason HD, Abdulwahid N, Tucker M and Morris DV (1985) Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet ii,1375-1378.
2. Amer SAK, Banu Z, Li TC, Ledger WL and Cooke ID (2002) Long-term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: Endocrine and ultrasonographic outcomes. Hum Reprod 17,2851-2857.
3. Amer SA, Li TC and Ledger WL (2004) Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod 19,1719-1724.
4. Anderson RA, Groome NP and Baird DT (1998) Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin Endocrinol (Oxf) 48,577-584.
5. Anttila L, Koskinen P, Kaihola HL, Erkkola R, Irjala K and Ruutiainen K (1992) Serum androgen and gonadotrophin concentrations decline after progestogen-induced withdrawal bleeding in oligomenorrhoeic women with or without polycystic ovaries. Fertil Steril 58,697-702.
6. Armar NA, McGarrigle HHG, Honour J, Holownia P, Jacobs HS and Lachelin GCL (1990) Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: Endocrine changes and clinical outcome. Fertil Steril 53,45-49.
7. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S and Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovarian syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85,2434-2438.
8. Bili H, Laven J, Imani B, Eijkemans MJC and Bart CJM (2001) Age-related differences in features associated with polycystic ovarian syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol 145,749-755.
9. Carter GD, Holland SM, Alaghband-Zadeh J, Rayman G, Dorrington-Ward P and Wise PH (1983) Investigation of hirsutism: Testosterone is not enough. Ann Clin Biochem 20,262-263.
10. Cortet-Rudelli C, Pigny P, Decanter C, Leroy M, Maunoury-Lefebvre C, Thomas-Desrousseaux P and Dewailly D (2002) Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovarian syndrome. Fertil Steril 77,281-287.
11. Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J and Pawson M (1988) Elevated free androgen index as an indicator of polycystic ovaries in oligomenorrhoea without obesity or hirsuties. Ann Clin Biochem 25,346-349.
12. Elting MW, Kwee J, Schats R, Rekers-Mombarg LT and Schoemaker J (2001) The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovarian syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. J Clin Endocrinol Metab 86,1589-1595.
13. Felemban A, Tan SL and Tulandi T (2000) Laparoscopic treatment of polycystic ovaries with insulated needle cautery: A reappraisal. Fertil Steril 73,266-269.
14. Franks S (1995) Polycystic ovarian syndrome. N Engl J Med 333,853-861.
15. Franks S (2002) Adult polycystic ovarian syndrome begins in childhood. Best Pract Res Clin Endocrinol Metab 16,263-272.
16. Franks S, Robinson S and Willis DS (1996) Nutrition, insulin and polycystic ovarian syndrome. Rev Reprod 1,47-53.
17. Gjonnaess H and Norman N (1987) Endocrine effects of the ovarian electrocautery in patients with polycystic ovarian disease. Br J Obstet Gynaecol 94,779-783.
18. Greenblatt E and Casper RF (1987) Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. Am J Obstet Gynecol 156,279-285.
19. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP and McNeilly AS (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81,1401-1405.
20. Hillier SG (1991) Regulatory functions for inhibin and activin in human ovaries. J Endocrinol 131,171-175.
21. Homburg R, Weissglas L and Goldman J (1988) Improved treatment for anovulation in polycystic ovarian disease utilizing the effect of progesterone on the inappropriate gonadotrophin release and clomiphene response. Hum Reprod 3,285-288.
22. van Hooff MHA, van der Meer M, Lambalk CB and Schoekaker J (1999) Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovarian syndrome. Hum Reprod 14,1684-1689.
23. Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies. Gynecol Endocrinol 1,235-245.
24. Laven JS, Imani B, Eijkemans MJ, de Jong FH and Fauser BC (2001) Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovarian syndrome in normogonadotrophic anovulatory infertility. Hum Reprod 16,1359-1364.
25. Li TC, Saravelos H, Chow MS, Chisabingo R and Cook ID (1998) Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynaecol 105,338-344.
26. Li TC, Spuijbroek MDEH, Tuckerman E, Anstie B, Loxley M and Laird S (2000) Endocrinological and endometrial factors in recurrent miscarriage. Br J Obstet Gynaecol 107,1471-1479.
27. Liguori G, Tolino A, Moccia G, Scognamiglio G and Nappi C (1996) Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): Endocrine changes and clinical outcome. Gynaecol Endocrinol 10,257-264.
28. Lockwood GM, Muttukrishna S, Groome NP, Knight PG and Ledger WL (1996) Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin Endocrinol (Oxf) 45,741-748.
29. Lockwood GM, Muttukrishna S, Groome NP, Matthews DR and Ledger WL (1998) Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: A possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 83,1730-1735.
30. Minakami H, Abe N, Izumi A and Tamada T (1988) Serum luteinizing hormone profile during the menstrual cycle in polycystic ovarian syndrome. Fertil Steril 50,990-992.
31. Norman RJ, Milner CR, Groome NP and Robertson DM (2001) Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum Reprod 16,668-672.
32. Pigny P, Cortet-Rudelli C, Decanter C, Deroubaix D, Soudan B, Duhamel A and Dewailly D (2000) Serum levels of inhibins are differentially altered in patients with polycystic ovarian syndrome: Effects of being overweight and relevance to hyperandrogenism. Fertil Steril 73,972-977.
33. Prelevic GM, Wurzburger MI and Balint Peric L (1990) LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovarian syndrome. Gynecol Endocrinol 4,1-13.
34. Shen ZJ, Chen XP and Chen YG (2005) Inhibin B, activin A, and follistatin and the pathogenesis of polycystic ovarian syndrome. Int J Gynaecol Obstet 88,336-337.
35. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D and Hall JE (1997) Determinants of abnormal gonadotrophin secretion in clinically defined women with polycystic ovarian syndrome. J Clin Endocrinol Metab 82,2248-2256.
36. Torgac M, Kokcu A, Cetinkaya MB, Alper T and Malatyalioglu E (2005) Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovarian syndrome? Gynecol Endocrinol 20,322-326.
37. Welt CK and Schneyer AL (2001) Differential regulation of inhibin B and inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 86,330-336.
38. Welt CK, Taylor AE, Martin KA and Hall JE (2002) Serum inhibin B in polycystic ovarian syndrome: Regulation by insulin and luteinizing hormone. J Clin Endocrinol Metab 87,5559-5565.
39. Yen SSC (1991) Chronic anovulation caused by peripheral endocrine disorders. In Yen SSC and Jaffe RB (eds) Reproductive Endocrinology, 3rd edn. WB Saunders, Philadelphia, pp. 576-630.